Tunisia

Last Updated 17 September 2021.

6 Vaccines Approved for Use in Tunisia

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 99 countries

  33 trials in 17 countries

  Approval Source: santetunisie.rns.tn

  RNA

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 71 countries

  21 trials in 7 countries

  Approval Source: tass.com

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 64 countries

  11 trials in 17 countries

  Approval Source: sauve.tn

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 121 countries

  40 trials in 21 countries

  Approval Source: aa.com.tr

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 64 countries

  14 trials in 8 countries

  Approval Source: xinhuanet.com

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 40 countries

  19 trials in 7 countries

  Approval Source: xinhuanet.com

  Inactivated

0 Vaccines in Clinical Trials in Tunisia